| Title |
Pharmacovigilance in developing countries (part I): importance and challenges
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, December 2017
|
| DOI | 10.1007/s11096-017-0570-z |
| Pubmed ID | |
| Authors |
Shaimaa Elshafie, Iman Zaghloul, Anne Marie Roberti |
| Abstract |
The thalidomide disaster was the significant historical event that acted as a catalyst for pharmacovigilance activity. Following this event developed countries initiated drug monitoring systems that evolved and now extend their scope to broader drug-related safety issues; however, this was not the case in developing countries. Pharmacovigilance is still a relatively new concept with low priority in developing countries although various issues are raising concerns that magnify the need for systems to monitor post marketing drug safety in these countries. This article analyzes the barriers to introducing robust pharmacovigilance systems in developing countries. |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 12% |
| India | 2 | 12% |
| Panama | 2 | 12% |
| United Kingdom | 2 | 12% |
| Pakistan | 1 | 6% |
| Japan | 1 | 6% |
| Sweden | 1 | 6% |
| Spain | 1 | 6% |
| El Salvador | 1 | 6% |
| Other | 0 | 0% |
| Unknown | 4 | 24% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 88% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 111 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 15% |
| Student > Bachelor | 11 | 10% |
| Student > Doctoral Student | 10 | 9% |
| Student > Ph. D. Student | 8 | 7% |
| Other | 5 | 5% |
| Other | 16 | 14% |
| Unknown | 44 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 30 | 27% |
| Medicine and Dentistry | 17 | 15% |
| Nursing and Health Professions | 8 | 7% |
| Agricultural and Biological Sciences | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | <1% |
| Other | 5 | 5% |
| Unknown | 46 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2018.
All research outputs
#3,309,142
of 25,732,188 outputs
Outputs from International Journal of Clinical Pharmacy
#170
of 1,600 outputs
Outputs of similar age
#68,063
of 446,422 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#3
of 25 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,422 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.